Volume 13, Issue 8, Pages (August 2006)

Slides:



Advertisements
Similar presentations
URB754 Has No Effect on the Hydrolysis or Signaling Capacity of 2-AG in the Rat Brain Susanna M. Saario, Ville Palomäki, Marko Lehtonen, Tapio Nevalainen,
Advertisements

Context-Specific Target Definition in Influenza A Virus Hemagglutinin-Glycan Receptor Interactions Zachary Shriver, Rahul Raman, Karthik Viswanathan, Ram.
LDAI-Based Chemical Labeling of Intact Membrane Proteins and Its Pulse-Chase Analysis under Live Cell Conditions Takayuki Miki, Sho-hei Fujishima, Kazuhiro.
Volume 20, Issue 3, Pages (March 2013)
Volume 13, Issue 8, Pages (August 2006)
Rational Design of Combination Enzyme Therapy for Celiac Sprue
Volume 12, Issue 6, Pages (June 2005)
Nucleosomes and Cisplatin
An Unnatural PIP Simulates Growth Factor Signaling
Volume 22, Issue 5, Pages v-vi (May 2015)
An Opiate Cocktail that Reduces Morphine Tolerance and Dependence
Nucleosomes and Cisplatin
Volume 17, Issue 6, Pages (June 2010)
Foundations for Directed Alkaloid Biosynthesis
Volume 59, Issue 1, Pages (January 2001)
Scratch n’ Screen for Inhibitors of Cell Migration
Chemical Proteomics of Host-Pathogen Interaction
Volume 20, Issue 11, Pages (November 2013)
Molecular fMRI of Serotonin Transport
Volume 20, Issue 3, Pages (March 2013)
Adding Specificity to Artificial Transcription Activators
Jacqueline L. Blankman, Gabriel M. Simon, Benjamin F. Cravatt 
Volume 17, Issue 10, Pages (October 2010)
JAK3 Specific Kinase Inhibitors: When Specificity Is Not Enough
Volume 16, Issue 22, Pages (November 2006)
Volume 18, Issue 8, Pages (August 2011)
Volume 12, Issue 6, Pages (June 2005)
Volume 23, Issue 4, Pages (April 2016)
Rational Design of Combination Enzyme Therapy for Celiac Sprue
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
Volume 22, Issue 7, Pages (July 2015)
Volume 15, Issue 11, Pages (November 2008)
A Noncanonical Path to Mechanism of Action
Volume 59, Issue 1, Pages (January 2001)
No Need To Be Pure: Mix the Cultures!
Volume 15, Issue 20, Pages (October 2005)
Volume 19, Issue 6, Pages (June 2012)
Volume 19, Issue 6, Pages (June 2012)
Volume 20, Issue 2, Pages (February 2013)
Bioactive Peptides from Libraries
FOXP2 and Human Cognition
Volume 15, Issue 4, Pages (April 2008)
Volume 21, Issue 5, Pages (May 2014)
Volume 19, Issue 11, Pages (November 2012)
Volume 5, Issue 9, Pages (September 1995)
Volume 21, Issue 8, Pages v-vi (August 2014)
Volume 14, Issue 12, Pages (December 2007)
Foundations for Directed Alkaloid Biosynthesis
Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism  Jonathan Z. Long, Daniel.
Volume 22, Issue 7, Pages (July 2015)
Dopamine Receptor Activation By Honey Bee Queen Pheromone
Array-Based Functional Screening of Heparin Glycans
Volume 22, Issue 8, Pages (August 2015)
Volume 13, Issue 4, Pages (April 2006)
Volume 16, Issue 11, Pages (September 2016)
Protein Kinase D Inhibitors Uncouple Phosphorylation from Activity by Promoting Agonist-Dependent Activation Loop Phosphorylation  Maya T. Kunkel, Alexandra C.
Volume 17, Issue 10, Pages (October 2010)
Volume 18, Issue 5, Pages (May 2011)
L-DOPA Ropes in tRNAPhe
Colin Rickman, Bazbek Davletov  Chemistry & Biology 
Volume 21, Issue 9, Pages (September 2014)
Unmodified Cadmium Telluride Quantum Dots Induce Reactive Oxygen Species Formation Leading to Multiple Organelle Damage and Cell Death  Jasmina Lovrić,
Volume 18, Issue 11, Pages (November 2011)
Aaron T. Wright, Benjamin F. Cravatt  Chemistry & Biology 
Tools to Tackle Protein Acetylation
Volume 14, Issue 8, Pages (August 2007)
2-AG + 2 New Players = Forecast for Therapeutic Advances
Volume 21, Issue 9, Pages (September 2014)
Volume 15, Issue 11, Pages (November 2008)
A New Fluorescence-Based Assay for Autophagy
Presentation transcript:

Volume 13, Issue 8, Pages 811-814 (August 2006) URB754 Has No Effect on the Hydrolysis or Signaling Capacity of 2-AG in the Rat Brain  Susanna M. Saario, Ville Palomäki, Marko Lehtonen, Tapio Nevalainen, Tomi Järvinen, Jarmo T. Laitinen  Chemistry & Biology  Volume 13, Issue 8, Pages 811-814 (August 2006) DOI: 10.1016/j.chembiol.2006.07.008 Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 1 Hydrolysis of 2-AG in NAM, URB754, and URB602 Pretreated Rat Cerebellar Membranes, Brain Homogenate, and Cerebellar Homogenate The enzyme activity of control samples was expressed as 100%. The data represent the mean ± SD from three independent experiments performed in duplicate. An asterisk denotes a statistically significant (∗p < 0.05) difference from the respective control. CbM, pretreated rat cerebellar membranes; BrH, brain homogenate; CbH, cerebellar homogenate. Chemistry & Biology 2006 13, 811-814DOI: (10.1016/j.chembiol.2006.07.008) Copyright © 2006 Elsevier Ltd Terms and Conditions

Figure 2 Treatment of Rat Brain Sections with PMSF Allows Detection of 2-AG-Stimulated G Protein Activity throughout the CB1 Receptor-Enriched Brain Regions, Whereas Similar Treatment with URB754 Is Ineffective Horizontal brain sections were processed for [35S]GTPγS autoradiography using a three-step assay protocol as detailed in the Experimental Procedures. PMSF (1 mM) was present in step 2, and URB754 (10 μM) throughout steps 2 and 3. [35S]GTPγS labeling was conducted for 90 min under basal conditions or in the presence of the cannabinoid agonists. Note that in PMSF-treated sections, 2-AG and the synthetic cannabinoid agonist CP55,940 stimulate [35S]GTPγS binding to the same CB1 receptor-enriched brain regions, most notably in the caudate putamen (CPu), the globus pallidus (GP), the hippocampus (hip), and the cerebral cortex (Ctx). Note also that URB754 totally lacks such a 2-AG signal-enhancing effect. Chemistry & Biology 2006 13, 811-814DOI: (10.1016/j.chembiol.2006.07.008) Copyright © 2006 Elsevier Ltd Terms and Conditions